HPV

Showing    of 2 results

Team at UH Seidman Cancer Center Identifies Robust Immune Biomarker Predicting Survival in HPV-positive Head and Neck Squamous Cell Carcinoma

Findings can guide which patients are best candidates for de-escalation strategies - Innovations in Cancer | March 2021

Taking the Helm

A conversation with Ted Teknos, MD, new President of UH Seidman Cancer Center Innovations in Cancer - Winter 2018    TED TEKNOS, MD Q: What are the most important trends in cancer care right now and how is UH Seidman Cancer Center positioned to...

Results are loading...